Sentinel lymph node biopsy in melanoma: A micromorphometric study relating to prognosis and completion lymph node dissection

British Journal of Dermatology

Volumn 157, Issue 1, 2007, Pages 58-67

  Debarbieux, S ^a   Duru, G ^b   Dalle, S ^a   Beatrix O ^c   Balme, B ^a   Thomas, L ^a  

^a HÔTEL DIEU   (France)

^b UNIVERSITÉ LYON 1   (France)

^c CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Melanoma; Prognosis; Sentinel lymph node

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER INVASION; CANCER SIZE; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LOG RANK TEST; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; MORPHOMETRICS; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SENTINEL LYMPH NODE BIOPSY; SURVIVAL TIME; ULCER;

ADULT; AGED; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 34250679266     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.07937.x     Document Type: Article

References (22)

1. Cochran AJ, Balda BR, Starz H et al. The Augsburg Consensus. Techniques of lymphatic mapping, sentinel lymphadenectomy, and completion lymphadenectomy in cutaneous malignancies. Cancer 2000 89 : 236 41.
2. Thompson JF, McCarthy WH, Bosch CM et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995 5 : 255 60.
3. Gershenwald JE, Thompson W, Mansfield PF et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999 17 : 976 83.
4. Dalle S, Paulin C, Lapras V et al. Fine-needle aspiration with ultrasound guidance in patients with malignant melanoma and palpable lymph nodes. Br J Dermatol 2006 155 : 552 6.
5. Balch CM, Soong SJ, Bartolucci AA et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 1996 224 : 255 63 discussion 263 6.
6. Cascinelli N, Morabito A, Santinami M et al. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet 1998 351 : 793 6.
7. Wrightson WR, Wong SL, Edwards MJ et al. Complications associated with sentinel lymph node biopsy for melanoma. Ann Surg Oncol 2003 10 : 676 80.
8. Morton DL, Wen DR, Wong JH et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992 127 : 392 9.
9. Lee JH, Essner R, Torisu-Itakura H et al. Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma. J Clin Oncol 2004 22 : 3677 84.
10. Cochran AJ, Lana AM, Wen DR. Histomorphometry in the assessment of prognosis in stage II malignant melanoma. Am J Surg Pathol 1989 13 : 600 4.
11. Starz H, Balda BR, Kramer KU et al. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer 2001 91 : 2110 21.
12. Starz H, Siedlecki K, Balda BR. Sentinel lymphonodectomy and S-classification: a successful strategy for better prediction and improvement of outcome of melanoma. Ann Surg Oncol 2004 11 (Suppl. 3 162S 8S.
13. Ranieri JM, Wagner JD, Azuaje R et al. Prognostic importance of lymph node tumor burden in melanoma patients staged by sentinel node biopsy. Ann Surg Oncol 2002 9 : 975 81.
14. Cochran AJ, Wen DR, Huang RR et al. Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node. Mod Pathol 2004 17 : 747 55.
15. Wagner JD, Davidson D, Coleman JJ III. et al. Lymph node tumor volumes in patients undergoing sentinel lymph node biopsy for cutaneous melanoma. Ann Surg Oncol 1999 6 : 398 404.
16. Starz H, De Donno A, Balda BR. The Augsburg experience: histological aspects and patient outcomes. Ann Surg Oncol 2001 8 (Suppl. 9 48S 51S.
17. Carlson GW, Murray DR, Lyles RH et al. The amount of metastatic melanoma in a sentinel lymph node: does it have prognostic significance? Ann Surg Oncol 2003 10 : 575 81.
18. Reeves ME, Delgado R, Busam KJ et al. Prediction of nonsentinel lymph node status in melanoma. Ann Surg Oncol 2003 10 : 27 31.
19. Salti GI, Das Gupta TK. Predicting residual lymph node basin disease in melanoma patients with sentinel lymph node metastases. Am J Surg 2003 186 : 98 101.
20. Dewar DJ, Newell B, Green MA et al. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol 2004 22 : 3345 9.
21. Scolyer RA, Li LX, McCarthy SW et al. Micromorphometric features of positive sentinel lymph nodes predict involvement of nonsentinel nodes in patients with melanoma. Am J Clin Pathol 2004 122 : 532 9.
22. Ulrich J, Bonnekoh B, Bockelmann R et al. Prognostic significance of detecting micrometastases by tyrosinase RT/PCR in sentinel lymph node biopsies: lessons from 322 consecutive melanoma patients. Eur J Cancer 2004 40 : 2812 19.